ACPU
AGN

Arrowgrass Capital Partners (US)’s Allergan plc AGN Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-146,400
Closed -$23.9M – 522
2017
Q4 		$23.9M Buy
146,400
+144,936
+9,900% +$26M 0.23% 97
2017
Q3 		$30M Sell
1,464
-1,180
-45% -$274K 0.22% 103
2017
Q2 		$64.3M Buy
2,644
+2,479
+1,502% +$583K 0.49% 47
2017
Q1 		$3.94M Sell
165
-666
-80% -$155K 0.04% 357
2016
Q4 		$17.5M Buy
831
+110
+15% +$22.8K 0.2% 112
2016
Q3 		$16.6M Buy
721
+55
+8% +$13.4K 0.22% 96
2016
Q2 		$15.4M Sell
666
-50
-7% -$11.5K 0.16% 92
2016
Q1 		$19.2M Sell
716
-55
-7% -$15.7K 0.23% 75
2015
Q4 		$24.1M Buy
771
+716
+1,302% +$213K 0.29% 47
2015
Q3 		$1.5M Buy
+55
New +$16.9K 0.03% 295
2015
Q1 		– Sell
-900,000
Closed -$232M – 555
2014
Q4 		$232M Buy
+900,000
New +$225M 4.12% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s AGN Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 405,630 shares — an estimated $67.9M sold.

Arrowgrass Capital Partners (US) first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $282M in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 405,630 Allergan plc shares in Q3 2019, an estimated $67.9M.
  • Arrowgrass Capital Partners (US) first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Arrowgrass Capital Partners (US)'s Allergan plc position peaked at $282M in Q1 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.